Dear Colleagues,
Here is another query. If anyone could help I would be grateful if they would respond to Sarah directly.
All good wishes,
Olive
>>> "Shandall, Sarah" <[log in to unmask]> 01/04/2008 15:48 >>>
Good afternoon
I was searching your site and it is extremely interesting I was wondering of you had any information on
What is a landmark trial
What is an outcome trail
What is primary/secondary prevention
Why are landmark trials not repeated
Or if not would you know appropriate places to look?
Kind Regards
Sarah Shandall MbchB, BSc
AstraZeneca UK MC
Knowledge Advisor (Cardiovascular)
> J (+44) 1582 836 533
> * [log in to unmask]
> ______________________________________
> AstraZeneca UK Ltd, Horizon Place, 600 Capability Green, Luton, Beds LU1 3LU
>
AstraZeneca UK Limited
A company incorporated in England and Wales with Company no. 03674842
Registered office: 15 Stanhope Gate, London, W1K 1LN
VAT no. GB582323642
Confidentiality Notice: This message is private and confidential and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful.
Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email.
Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking compliance with our Code of Conduct and Policies.
|